Loading
Latest filing published 09 Oct 2026 for Allarity Therapeutics, Inc..
Not enough history yet: 1 closed purchase, at least 2 are needed.
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Jeremy R. Graff discloses dealings in 2 companies, chiefly Allarity Therapeutics, Inc. and In8bio, Inc. The record holds 12 filings, for trades running from 13 September 2023 to 30 September 2026.
On the market, this insider has only ever bought: 1 purchase, €2,213 in total. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. Other entries cover 8 share grants and 3 option exercises.
The newest entry dates from 9 October 2026: an option exercise, in Allarity Therapeutics, Inc. The most recent open-market purchase was published on 15 September 2023, 1,135 days ago. The median gap between a trade and its publication by SEC (Form 4) is 6 days. The legal deadline for a Form 4 is two business days after the transaction. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
11 of 11 declarations